Effects of continuous intravenous infusion of propofol on intestinal flora in rats.


Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 23 08 2020
revised: 19 11 2020
accepted: 28 11 2020
pubmed: 19 12 2020
medline: 2 7 2021
entrez: 18 12 2020
Statut: ppublish

Résumé

Under normal circumstances, the gut microbiota, host, and external environment establish a dynamic ecological balance and maintain human health. Once this balance is broken, the intestinal flora dysregulation will form, manifested by changes in the diversity, richness, proportion, location and biological characteristics of the gut microbiota. The hypothesis that propofol alters gut microbes was tested in a rat model with continuous intravenous infusion of propofol. Eight male wistar rats underwent tail vein puncture and catheterization respectively, and were continuously pumped with propofol for 3 h. Feces were collected from each rat before and on the 1 st, 3rd, 7th and 14th days after intervention. Finally, the effect of continuous intravenous infusion of propofol on the intestinal flora of rats was analyzed by high-throughput 16S rRNA gene amplification sequencing. Through high-throughput 16S rRNA gene amplicon sequencing analysis, we found that continuous intravenous infusion of propofol had little effect on intestinal flora in rats. Analysis of Alpha (shannon diversity index) showed that group A-7 was different from group P and group A-1 (P = 0.034), and recovered on the 14th day. Although the species diversity analysis showed a significant difference among the five groups (P = 0.049), the distribution of most fecal samples in the PCoA showed a clustered distribution, indicating similarity. In addition, no significant difference was found in the statistical KEGG difference pathway through LEfSe analysis.

Identifiants

pubmed: 33338744
pii: S0753-3322(20)31273-7
doi: 10.1016/j.biopha.2020.111080
pii:
doi:

Substances chimiques

Anesthetics, Intravenous 0
RNA, Ribosomal, 16S 0
Propofol YI7VU623SF

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111080

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Nana Guo (N)

Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: guonanaicu2@163.com.

Zhongjie Zhang (Z)

Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: 1083746593@qq.com.

Ci Han (C)

Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: 405670830@qq.com.

Lu Chen (L)

Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: chenlurico@163.com.

Xiaoya Zheng (X)

Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: zhengxiaoya555@163.com.

Kaili Yu (K)

Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: yukaili1543@163.com.

Zhaodi Zhang (Z)

Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: jody1982@163.com.

Changsong Wang (C)

Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: changsongwangicu@163.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH